The new 300µL interlocked robotic arm machine (RAM) vial with 9mm thread finish from J G Finneran Associates based in Vineland, NJ, US is aimed at researchers tasked with managing a high number of chromatography sample vials in their laboratories.
Composed of a clear or amber Type I borosilicate glass, the vial and insert are fused together keeping the insert permanently in place. This enables accurate automated injection and eliminates contamination risk around the seam or space between the neck of the vial and the insert. The interlocked RAM vial arrives ready to use saving valuable time in the laboratory.
The vial has been designed to work in robotic arm autosamplers such as those available from Agilent Technologies and others. Robotic arms can easily grasp the 12mm x 32mm outer dimensions of the vial. Chromatography samples are contained in a clear Type I borosilicate glass 300µL conical tip insert. The interlocked RAM vial includes a marking spot, which can be written on with a #2 pencil. The vial is also available with a 9mm screw thread closure.
Interlocked RAM vial provides safe sample containment
For researchers managing a high number of chromatography sample vials
You may also like
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Scaling complexity without losing control: how manufacturing processes are adapting to the next generation of medicines (part V)
Read moreAs therapies grow more complex, manufacturers must build commercial-scale thinking into early development, focus on meaningful monitoring and favour simplicity to keep production predictable
Trending Articles
You may also like
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Manufacturing
Scaling complexity without losing control: how manufacturing processes are adapting to the next generation of medicines (part V)
As therapies grow more complex, manufacturers must build commercial-scale thinking into early development, focus on meaningful monitoring and favour simplicity to keep production predictable
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Manufacturing
Scaling complexity without losing control: how manufacturing processes are adapting to the next generation of medicines (part IV)
Real-time monitoring, digital-first platforms and early scalability planning can help manufacturers to maintain quality, flexibility and speed as dosage forms become more sophisticated
Analysis
Inspection readiness should be part of normal operations
For routine surveillance inspections, readiness cannot depend on receiving advance notice. Inspection readiness should be embedded in everyday operations, while recognising that preparation may need to become more intensive ahead of a known regulatory milestone